People
Karl Kieburtz
Karl Kieburtz became Cerevance’s chief medical officer in October 2026. He is a University of Rochester neurologist and co-founder of Clintrex Research, with extensive Parkinson’s disease trial experience.
Roles
Modality.AI
CurrentDistinguished Presidential Appointee
Neumirna Therapeutics
CurrentScientific Advisory Board Member, Parkinson's Disease
Cerevance
CurrentChief Medical Officer